CapForce IBD Breakout Opportunities ETF

C000272877 Fund Overview

CapForce IBD Breakout Opportunities ETF is a US ETF managed by Capital Force ETF Trust, categorised as United States Multi-Cap / All-Cap Growth Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.

• Type: US ETF
• Manager: Capital Force ETF Trust
• Category: United States Multi-Cap / All-Cap Growth Equity
• Assets under management: $16.18M
• SEC CIK: 0002104659
• SEC series ID: S000102392
• Share class ID: C000272877

C000272877 Investment Objective and Strategy

CapForce IBD Breakout Opportunities ETF describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Capital Force ETF Trust.

Investment objective

The Fund seeks to track, before fees and expenses, the performance of the IBD O Breakout Stocks Index (the Index ).

Principal investment strategy

The Fund will normally invest at least 80% of its net assets (including investment borrowings) in the equity securities that comprise the Index. The Fund generally invests in all of the securities comprising the Index in proportion to the weightings of the securities in the Index. The Fund, using an indexing investment approach, attempts to replicate, before fees and expenses, the performance of the Index. The Funds investment sub-adviser, Penserra Capital Management LLC (Penserra or the Sub-Adviser ), seeks to achieve a high degree of correlation with the Index in order to minimize tracking error, which is the variation between the Funds annual return and the return of the Index. The Index is a rules-based index owned and developed by Investors Business Daily ( IBD or the Index Provider ) that seeks to provide opportunistic investment exposure to those stocks with the potential to break out, or experience a period of sustained price growth beyond the stocks recent resistance level, with consideration for various market conditions.

A stocks resistance level is the price at which a stock has previously reached, but not exceeded. Determining a stocks resistance level is part of a technical analysis of the stock and represents the top of its expected price trading range. The Indexs initial universe consists of the approximately 7,000 equity securities that trade on the New York Stock Exchange, The Nasdaq Stock Market, LLC or NYSE American, LLC. This initial universe is composed of U.S.-listed common stocks and American depositary receipts ( ADRs ) issued by small, mid and large capitalization companies. Such securities may be issued by U.S. and non-U.S. companies, including companies operating in developed and emerging markets. This universe is initially narrowed down by excluding those stocks with a share price below $10 and those stocks without an average daily trading volume of at least 150,000 shares or a minimum average daily dollar volume of $5 million.

The Index then determines a base price for each remaining stock. When a stock reaches a recent high in price and at least four weeks elapse without that high being surpassed, this price is identified as the base price. This base is used to determine those stocks nearing breakouts and those stocks experiencing breakouts. In making this determination, the Index utilizes an algorithm that analyses the following trends for each stock: 1. The length of time from the start of the base to the current date. 2. The difference in price between the base start and the lowest subsequent price in the base. 3. The percentage difference between the current price and the high at the start of the base. 4. The percentage change in the stocks price in each of the last three weeks. Based upon this technical analysis, the Index eliminates all stocks not identified as nearing a breakout or currently breaking out.

Then, stocks are further eliminated that do not meet minimum technical and fundamental factors (primarily price performance, earnings growth, and sales growth). Each of the remaining stocks is chosen for inclusion in the Index and is assigned a ranking score using IBDs Composite Ranking, based upon the following components: Earnings Per Share Rating, Relative Price Strength Rating, Industry Group Relative Strength Rating, Sales Margins Return on Equity ( SMR ) Rating, Accumulation Distribution Rating and Percentage Deviation from 52-week Price High. The Index utilizes this ranking score to assign weights, with those stocks with higher rankings receiving larger weights. Securities with ranking scores placing them in approximately the 99-80th percentile of Index constituents have 35% of Index weight equally distributed among them.

Securities with ranking scores placing them in approximately the 79-60th percentile of Index constituents have 30% of Index weight equally distributed among them. Securities with ranking scores placing them approximately in the 59-40th percentile of Index constituents have 20% of Index weight equally distributed among them. Securities with ranking scores placing them in approximately the 39-20th percentile of Index constituents have 10% of the Index weight equally distributed among them. The remaining securities have 5% of the Index weight equally distributed among them. Additional information regarding the Indexs weighting methodology is set forth in Index InformationIndex Composition. The Index is rebalanced and reconstituted weekly. This weekly rebalancing and reconstituting of the Index will cause the Fund to have a higher portfolio turnover rate than similar funds.

The Fund is classified as a non-diversified company under the 1940 Act. To the extent the Index concentrates ( i.e ., holds 25% or more of its total assets) in the securities of a particular industry or group of industries, the Fund will concentrate its investments to approximately the same extent. As of the date of this prospectus, the Fund has significant exposure to the consumer discretionary, industrials and information technology sectors.

C000272877 Holdings

Top 10 holdings of CapForce IBD Breakout Opportunities ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.

View all C000272877 holdings

C000272877 Portfolio Allocation

Asset-class allocation of CapForce IBD Breakout Opportunities ETF by percentage of net assets, from the latest SEC N-PORT filing.

C000272877 Performance

Total returns for C000272877 (as of 2026-10-01), from SEC filings.

C000272877 Costs and Fees

C000272877 costs about $80 per $10,000 invested per year in fund expenses.

• Net expense ratio: 0.80%
• Gross expense ratio: 1.00%
• Portfolio turnover: 1668%

C000272877 Cashflows

Over the 12 months to 2026-04, CapForce IBD Breakout Opportunities ETF had net inflows of $0, from monthly SEC N-PORT filings.

C000272877 Debt Constituents

No individual debt constituents are reported in CapForce IBD Breakout Opportunities ETF's latest SEC N-PORT filing.

C000272877 Prospectus and SEC Filings

Official CapForce IBD Breakout Opportunities ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.

• Prospectus supplement (497) — filed 2026-04-23
• Portfolio holdings (N-PORT) — filed 2026-09-21
• Portfolio holdings (N-PORT) — filed 2026-06-25

Related Funds

Other United States Multi-Cap / All-Cap Growth Equity funds tracked on ABC INVEST:

• American Funds Growth Portfolio (RGWFX)
• American Funds Growth and Income Portfolio (GAIOX)
• American Funds Global Growth Portfolio (PGGAX)
• PRIMECAP Odyssey Aggressive Growth Fund (POAGX)
• FullerThaler Behavioral Small Cap Growth Fund (FTXNX)

Data Sources

ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.